You’ve mastered the science. Now it’s time to master the company you’re building.
Most first-time biotech CEOs enter the role prepared for the science, but unprepared for the business decisions that determine whether that science ever reaches patients. The biggest failures in biotech rarely stem from weak data. They come from predictable missteps: scaling too fast, underestimating timelines, misreading investor expectations, choosing the wrong development path or partnering too early.
This free, expert-driven playbook breaks down the seven most critical decisions every first-time CEO must navigate: from early strategy and funding, to regulatory planning, partnerships and preclinical development.